Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
about
Follicular CD8+ T Cells: Origin, Function and Importance during HIV Infection.Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade.Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives.Trial watch: Immune checkpoint blockers for cancer therapy.MEK inhibition and immune responses in advanced melanoma.The perfect personalized cancer therapy: cancer vaccines against neoantigens.MEK inhibitors for the treatment of NRAS mutant melanomaMolecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
P2860
Q43119125-6D3FB2F2-D985-4006-BF6D-8D50197D8723Q47135020-5C440D2B-2B7B-45FE-8805-EDD9FF9EEE76Q47375181-0135609D-B03D-46E5-B4FC-0DE888EDF769Q47393365-54B31844-8899-460D-B56A-CB1D1A45C0F5Q54146041-BD33F8DF-5AFE-4E75-8388-B7574EDCC3DDQ55001351-01A2D714-29CD-4EDF-9965-DE6BE3DDD0C1Q56889985-7070AEF4-3BA0-4ED8-9990-7AAA4BFA0573Q58739937-C314074A-038C-4401-B3AA-E3FAEAFC7D87
P2860
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
@en
type
label
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
@en
prefLabel
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
@en
P2093
P2860
P50
P1433
P1476
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
@en
P2093
Christian U Blank
Christoph Hoeller
Cristina Pineda
Inge Verbrugge
Ji-Ying Song
John B A G Haanen
Jules Gadiot
Marcel A Deken
Marnix H Geukes Foppen
Melissa van Gool
P2860
P304
P356
10.1080/2162402X.2016.1238557
P577
2016-10-14T00:00:00Z